In the BioHarmony Drug Report Database

"Preview" Icon

Simoctocog alfa

Nuwiq, Vihuma (simoctocog alfa) is a protein pharmaceutical. Simoctocog alfa was first approved as Nuwiq on 2014-07-22. It is used to treat factor VII deficiency, hemophilia a, hemorrhage, and von willebrand diseases in the USA. It has been approved in Europe to treat hemophilia a.


Trade Name


Nuwiq, Vihuma

Common Name


simoctocog alfa






factor vii deficiency, hemophilia a, hemorrhage, von willebrand diseases

Drug Class


Image (chem structure or protein)

Simoctocog alfa structure rendering